Sida Shen

11PUBLICATIONS
13CO-AUTHORS
Biologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)Reaction engineering (excl. nuclear reactions)Cheminformatics and quantitative structure-activity relationshipsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 16, 2026
An updated patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2020-2025).

|Feb 11, 2023
Structural and Mechanistic Basis for the Inactivation of Human Ornithine Aminotransferase by (3S,4S)-3-Amino-4-fluorocyclopentenecarboxylic Acid.

Sida Shen, Arseniy Butrin, Brett A Beaupre

|Jun 07, 2021
Turnover and Inactivation Mechanisms for (S)-3-Amino-4,4-difluorocyclopent-1-enecarboxylic Acid, a Selective Mechanism-Based Inactivator of Human Ornithine Aminotransferase.

Sida Shen, Arseniy Butrin, Peter F Doubleday

|Apr 08, 2021
Tetrahydroquinoline-Capped Histone Deacetylase 6 Inhibitor SW-101 Ameliorates Pathological Phenotypes in a Charcot-Marie-Tooth Type 2A Mouse Model.

Sida Shen, Cristina Picci, Kseniya Ustinova

|Dec 14, 2020
Structural and Kinetic Analyses Reveal the Dual Inhibition Modes of Ornithine Aminotransferase by (1S,3S)-3-Amino-4-(hexafluoropropan-2-ylidenyl)-cyclopentane-1-carboxylic Acid (BCF3).

Arseniy Butrin, Brett A Beaupre, Noel Kadamandla

|Aug 21, 2020
Rational Design of Suprastat: A Novel Selective Histone Deacetylase 6 Inhibitor with the Ability to Potentiate Immunotherapy in Melanoma Models.

Satish Noonepalle, Sida Shen, Jakub Ptáček

Pageof 2

Frequent Collaborators

4 joint publications

Maurício T Tavares

4 joint publications

Guiping Zhang

4 joint publications

Cyril Bařinka

4 joint publications

Dali Liu